Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 16,697,754
- Share change
- +1,206,479
- Total reported value
- $10,681,727
- Put/Call ratio
- 0%
- Price per share
- $0.64
- Number of holders
- 37
- Value change
- -$1,110,269
- Number of buys
- 15
- Number of sells
- 25
Report period
Q2 2022
Institutions
37
Top holders
10
AQST full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
8.2%
|
9,810,958
|
$25,607,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,282,506
|
$3,347,000 | — | 31 Mar 2022 | |
| Vahanian & Associates Financial Planning Inc. |
13F
|
Company |
0.43%
|
520,158
|
$1,358,000 | — | 31 Mar 2022 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$1,119,000 | — | 31 Mar 2022 | |
| Graypoint LLC |
13F
|
Company |
0.34%
|
413,817
|
$1,080,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.31%
|
376,517
|
$983,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
268,556
|
$701,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
260,180
|
$679,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
254,497
|
$664,000 | — | 31 Mar 2022 | |
| Latash Investments, LLC |
13F
|
Company |
0.2%
|
243,134
|
$635,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.14%
|
166,355
|
$434,000 | — | 31 Mar 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.11%
|
130,305
|
$340,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
114,623
|
$299,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.09%
|
108,838
|
$284,000 | — | 31 Mar 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.08%
|
101,456
|
$265,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
100,000
|
$261,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
96,109
|
$250,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
96,037
|
$251,000 | — | 31 Mar 2022 | |
| Man Group plc |
13F
|
Company |
0.07%
|
89,900
|
$235,000 | — | 31 Mar 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.05%
|
63,577
|
$166,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
52,400
|
$137,000 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
52,252
|
$136,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
48,511
|
$126,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
48,312
|
$126,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
47,549
|
$124,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
36,790
|
$96,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.03%
|
34,810
|
$90,854 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
34,769
|
$91,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
34,300
|
$90,000 | — | 31 Mar 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.03%
|
31,396
|
$82,000 | — | 31 Mar 2022 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.02%
|
26,000
|
$68,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
25,027
|
$65,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
24,829
|
$65,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
22,100
|
$58,000 | — | 31 Mar 2022 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.02%
|
19,500
|
$51,000 | — | 31 Mar 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
13,385
|
$34,000 | — | 31 Mar 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
11,779
|
$34,000 | — | 31 Mar 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
11,140
|
$29,000 | — | 31 Mar 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
10,715
|
$28,000 | — | 31 Mar 2022 | |
| Running Point Capital Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$26,000 | — | 31 Mar 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0.01%
|
7,000
|
$112,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,582
|
$12,000 | — | 31 Mar 2022 | |
| Quantbot Technologies LP |
13F
|
Company |
0%
|
3,751
|
$9,000 | — | 31 Mar 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
3,166
|
$8,000 | — | 31 Mar 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
2,000
|
$5,000 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,000
|
$5,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,600
|
$4,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
842
|
$2,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
829
|
$2,000 | — | 31 Mar 2022 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
300
|
$1,000 | — | 31 Mar 2022 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2022
As of 30 Jun 2022,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,697,754 shares.
The largest 10 holders included
Bratton Capital Management, L.P., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Vahanian & Associates Financial Planning Inc., Bracebridge Capital, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Latash Investments, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
49
Q2 2022 holders
37
Holder diff
-12
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.